Home » FDA Greenlights LifeWatch’s Continuous Vital Signs Monitoring Service
FDA Greenlights LifeWatch’s Continuous Vital Signs Monitoring Service
LifeWatch has received FDA clearance for its continuous Vital Signs Monitoring Service.
The wireless, patch-based vital signs monitoring system is an easy-to-use, cable-free sensor worn on a patient’s upper chest, the company said.
The patch is intended to be used on adult patients in a clinical environment for the continuous, noninvasive monitoring of ECG, heart rate, respiration rate, surface temperature, arterial blood oxygen saturation and body position.
The product will be available in two versions — with and without ECG — and is connected with an easy-to-use wireless supporting system, which provides medical information and alerts. — Jonathon Shacat
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May